High-energy feedback microwave thermotherapy and intraprostatic injections of mepivacaine and adrenaline: an evaluation of calculated cell kill accuracy and responder rate
- 12 February 2014
- journal article
- research article
- Published by Medical Journals Sweden AB in Scandinavian Journal of Urology
- Vol. 48 (4) , 374-378
Abstract
Objective. The aim of this study was to evaluate cell kill accuracy and responder rate when using injections of intraprostatic mepivacaine and adrenaline (MA) before high-energy microwave thermotherapy (HE-TUMT). Material and methods. This retrospective evaluation encompassed 283 treatments in men with lower urinary tract symptoms or urinary retention due to benign prostatic hyperplasia. They were treated consecutively during 2003–2008 using HE-TUMT with a feedback technique. Immediately before treatment, MA was administered into the prostate via a Schelin Catheter®. Clinical outcome was evaluated 3 months after treatment using a validated symptom score, transrectal ultrasound, peak urinary flow and postvoid residual. Results. Systematic underestimation of the resulting coagulation necrosis was a consistent finding when using MA, a calculated cell kill of 21% yielding a volume reduction of 26% for prostate volumes less than 100 ml and 31% for prostate volumes greater than or equal to 100 ml. Mean prostate volume was 74 ml and mean treatment time was 13 min. Less than 1% of the patients needed analgesics or sedatives on demand. Analysis of the data showed an estimated clinical responder rate of approximately 87%. Conclusions. The resulting prostate volume reduction corresponds to the earlier empirically recommended 30% cell kill for CoreTherm® without MA. The treatment concept combining CoreTherm with intraprostatic injections of MA corresponds to the clinical outcome of thermotherapy without MA, with the benefits of reduced pain, shortened treatment time and decreased energy consumption.Keywords
This publication has 16 references indexed in Scilit:
- EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic ObstructionEuropean Urology, 2013
- Update on AUA Guideline on the Management of Benign Prostatic HyperplasiaJournal of Urology, 2011
- Five-Year Follow-up of Feedback Microwave Thermotherapy Versus TURP for Clinical BPH: A Prospective Randomized Multicenter StudyUrology, 2007
- Intraprostatic Blood-Flow Changes during ProstaLund Feedback Treatment Measured by Positron Emission TomographyJournal of Endourology, 2005
- Effects of Intraprostatic and Periprostatic Injections of Mepivacaine Epinephrine on Intraprostatic Blood Flow during Transurethral Microwave Thermotherapy: Correlation with [ 15 O]H 2 O-PETJournal of Endourology, 2004
- EAU 2004 Guidelines on Assessment, Therapy and Follow-Up of Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction (BPH Guidelines)European Urology, 2004
- Efficacy and Safety of Intraprostatic Temperature-Controlled Microwave Thermotherapy in Patients with Benign Prostatic Hyperplasia: Results of a Prospective, Open-Label, Single-Center Study with 1-Year Follow-UpJournal of Endourology, 2003
- AUA Guideline on Management of Benign Prostatic Hyperplasia (2003). Chapter 1: Diagnosis and Treatment RecommendationsJournal of Urology, 2003
- Feedback microwave thermotherapy versus TURP for clinical BPH—a randomized controlled multicenter studyUrology, 2002
- Mediating Transurethral Microwave Thermotherapy by Intraprostatic and Periprostatic Injections of Mepivacaine Epinephrine: Effects on Treatment Time, Energy Consumption, and Patient ComfortJournal of Endourology, 2002